uraa-quartely.blogspot.com
Howes, who also will serve as vice presideny forcorporate development, joins Akebia from Serenex. At that he was chief financial officeer and senior vice president forcorporatw development. “We are extremelyu pleased to have Ianjoin Akebia. He bringse a wealth of senior level financiao and corporate development experiencs and leadership tothe company,” Dr. Josepgh Gardner, CEO of Akebia, said in a presw release. “We have a number of very exciting program s under wayand Ian’s experience in capital management, corporate developmentg and operations will be essential in helpint the company successfully move into our next phasr of value creation.” At N.C.
-based Serenex, Howes helped generate $75 million in privatd equity and debt capital and managex the sale of the company to Pfizer. Before that, he was chief financial officer atParadigm “Akebia is expecting important near-term milestones including moving its first producrt into the clinic for anemiz and preparing to publish groundbreaking preclinical results for an additionalp program, making this a particularl y exciting time to join the company,” Howes said in the The Blue Ash-based company was formed in 2007 with programsz and assets licensed from when the consumedr goods maker turned its focus away from in-house drug Cincinnati-based was one of the original
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment